BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19965635)

  • 1. Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad.
    Frenzel A; Labi V; Chmelewskij W; Ploner C; Geley S; Fiegl H; Tzankov A; Villunger A
    Blood; 2010 Feb; 115(5):995-1005. PubMed ID: 19965635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf.
    Baumgartner F; Woess C; Pedit V; Tzankov A; Labi V; Villunger A
    Oncogene; 2013 Jan; 32(5):621-30. PubMed ID: 22430207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs.
    Happo L; Phipson B; Smyth GK; Strasser A; Scott CL
    Cell Death Dis; 2012 May; 3(5):e306. PubMed ID: 22573037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development.
    Labi V; Erlacher M; Kiessling S; Manzl C; Frenzel A; O'Reilly L; Strasser A; Villunger A
    J Exp Med; 2008 Mar; 205(3):641-55. PubMed ID: 18299399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    Wang J; Boxer LM
    J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.
    Michalak EM; Jansen ES; Happo L; Cragg MS; Tai L; Smyth GK; Strasser A; Adams JM; Scott CL
    Cell Death Differ; 2009 May; 16(5):684-96. PubMed ID: 19148184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
    Eischen CM; Alt JR; Wang P
    Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
    Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
    Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
    Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
    Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesis.
    Grespi F; Soratroi C; Krumschnabel G; Sohm B; Ploner C; Geley S; Hengst L; Häcker G; Villunger A
    Cell Death Differ; 2010 Nov; 17(11):1672-83. PubMed ID: 20706276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.
    Eischen CM; Woo D; Roussel MF; Cleveland JL
    Mol Cell Biol; 2001 Aug; 21(15):5063-70. PubMed ID: 11438662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma.
    Kelly PN; Puthalakath H; Adams JM; Strasser A
    Blood; 2007 Jun; 109(11):4907-13. PubMed ID: 17317859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
    Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
    Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
    J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and p73 in suppression of Myc-driven lymphomagenesis.
    Griesmann H; Schlereth K; Krause M; Samans B; Stiewe T
    Int J Cancer; 2009 Jan; 124(2):502-6. PubMed ID: 18942718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.
    Nemajerova A; Petrenko O; Trümper L; Palacios G; Moll UM
    J Clin Invest; 2010 Jun; 120(6):2070-80. PubMed ID: 20484818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.
    Gramling MW; Eischen CM
    Cell Death Differ; 2012 Jul; 19(7):1220-7. PubMed ID: 22301919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.